Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Related and Nonrelated Parties [Axis] Investor [Member] Timing of Transfer of Good or Service [Axis] Transferred at Point in Time [Member] Antidilutive Securities [Axis] Potentially Dilutive Securities [Member] Restricted Stock Units (RSUs) [Member] Warrant [Member] Statement of Income Location, Balance [Axis] Research and Development Expense [Member] General and Administrative Expense [Member] Counterparty Name [Axis] HCWG LLC [Member] Executive Chairman [Member] Sale of Stock [Axis] Private Placement [Member] Product and Service [Axis] Advisory Services [Member] Transaction Type [Axis] Equity Purchase Agreement [Member] Subsegments [Axis] NEO100 [Member] NEO100-02 [Member] NEO212 [Member] Pediatric [Member] Laboratory [Member] Plan Name [Axis] 2023 Equity Incentive Plan [Member] Award Type [Axis] Title and Position [Axis] Chief Executive Officer [Member] Two Members [Member] First Board Members [Member] Second Board Members [Member] Third Board Members [Member] Line of Credit Agreement [Member] HCWG [Member] Orient Euro Pharma Co Ltd [Member] Vendor [Member] Lease Agreement [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current Assets Cash and cash equivalents Deferred offering costs - current Debt issuance costs - current Prepaid expenses and other Total Current Assets Non-Current Assets Debt issuance costs - net of current portion Deferred offering costs - net of current portion Total Assets Liabilities and Shareholders’ Deficit Current Liabilities Accounts payable Accounts payable - related parties Accrued advisory fee - related party Litigation settlement payable Accrued compensation Total Current Liabilities Commitments and contingencies Shareholders’ Deficit: Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares were issued and outstanding as of March 31, 2025 and December 31, 2024 Common stock, $0.0001 par value, 100,000,000 shares authorized; 19,026,776 and 18,090,526 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively Additional paid in capital Accumulated deficit Total Shareholders’ Deficit Total Liabilities and Shareholders’ Deficit Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues: Revenue Operating Expenses: Research and development Legal and professional General and administrative Share based compensation Advisory fees Total Operating Expenses Loss From Operations Other Income and Expense: Interest income Amortization of debt issuance costs Interest expense - related parties Net Loss Loss per share: Basic net loss per common share Diluted net loss per common share Weighted average shares used in computing basic net loss per common share Weighted average shares used in computing diluted net loss per common share Statement [Table] Statement [Line Items] Balance - January 1, 2025 Beginning balance, shares Sale of common stock, net of offering costs Sale of common stock, net of offering costs, shares Common stock issued for advisory services Common stock issued for advisory services, shares Cashless exercise of warrants Cashless exercise of warrants, shares Stock based compensation Net loss Balance - March 31, 2025 Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Increase in bridge loan - expenses paid by bridge loan provider on behalf of the Company Accretion of original issue discount on bridge loans - related party Share based compensation - restricted stock Amortization of debt issuance costs and deferred offering costs Changes in operating assets and liabilities: Prepaid expenses Accrued compensation Accrued advisory fee Accounts payable - related parties Net cash provided by (used in) operating activities Cash flows from financing activities: Proceeds from the sale of common stock Proceeds from related party loan Repayment of related party loan Deferred offering costs Net cash provided by (used in) financing activities Net increase (decrease) in cash and cash equivalents Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Supplemental disclosure of non-cash financing activities: Original issue discount on bridge loan - related party Common stock issued in connection with private placement Right of use asset, at lease commencement Reclassification of deferred offering costs to APIC at the completion of the offering Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance Disclosure, Table Company Selected Measure Name Named Executive Officers, Footnote Peer Group Issuers, Footnote Changed Peer Group, Footnote PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote Equity Valuation Assumption Difference, Footnote Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Company Selected Measure Total Shareholder Return Vs Peer Group Compensation Actually Paid vs. Other Measure Tabular List, Table Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Company Selected Measure Amount Other Performance Measure, Amount Adjustment to Compensation, Amount PEO Name Name Non-GAAP Measure Description Additional 402(v) Disclosure Pension Benefits Adjustments, Footnote Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis Stock Price or TSR Estimation Method Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability Name Compensation Amount Restatement does not require Recovery Awards Close in Time to MNPI Disclosures [Table] Award Timing MNPI Disclosure Award Timing Method Award Timing Predetermined Award Timing MNPI Considered Award Timing, How MNPI Considered MNPI Disclosure Timed for Compensation Value Awards Close in Time to MNPI Disclosures, Table Name Underlying Securities Exercise Price Fair Value as of Grant Date Underlying Security Market Price Change Insider Trading Arrangements [Line Items] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Expiration Date Arrangement Duration Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Not Adopted Accounting Policies [Abstract] Description of Business and Liquidity Basis of Presentation and Summary of Significant Accounting Policies Related Party Transactions [Abstract] Related party transactions Related Party Loans Payable Related Party Loans Payable Leases [Abstract] Leases Common And Preferred Stock Common and Preferred Stock Segment Reporting [Abstract] Segment Reporting Stock-based Compensation Stock-Based Compensation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of presentation Principles of consolidation Use of estimates Cash and cash equivalents Deferred offering costs Debt issuance costs Warrants Leases Fair value measurements Revenue Research and development Patent costs Share-based compensation Net loss per share Income taxes Segment Reporting Schedule of debt Schedule of proceeds from the sale of common stock Schedule of segment reporting Schedule of restricted stock units activity Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Proposed sale of common stock Purchased shares of common stock Share price Total commitments Escrow released Cash Net loss Accumulated deficit Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Money market funds Anti-dilutive shares Current tax provision Upfront payment Amendment fees Advisory fee expense Advisory fee paid Annual patent maintenance fee Royalties percentage Utilizes laboratory and patent maintenance services Utilizes laboratory and patent maintenance services payable Accrued compensation Balance at beginning Borrowings OID Repayments Balance at end Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Maximum borrowing Bridge Loan Accretion of original issue discount Number of shares converted Due from related party Advances from related party Interest expense Base rent Lease increases percentage Right-of-use asset Lease liability Lease expense Cash paid for amounts included in the measurement of lease liability Lease discount rate Operating Lease term Gross proceeds from sale of common stock Reclassification of deferred offering costs to APIC at the completion of the offering Net proceeds from the sale of common stock Subsidiary or Equity Method Investee, Sale of Stock, Type [Table] Subsidiary, Sale of Stock [Line Items] Number of common stock Proceeds from issuance of private placement Release of restricted stock units Private placement description Total commitments Placement agent fees Advisory services fees Deferred offering costs Deferred offering costs incurred Amortization of debt issuance costs Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Revenues Total clinical trial expense Advisory fee Legal and accounting Travel Debt issuance and deferred offering costs amortization Investor relations General and administrative expense Interest expense - related parties' loans Interest income Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Restricted stock units, at beginning Restricted stock units, granted Restricted stock units, cancelled Restricted stock units, at ending Released restricted stock units Stock available for issuance Restricted stock units, granted Restricted stock units, cancelled Fair value of RSUs Share-based compensation Unamortized stock-based compensation Unamortized stock-based compensation, term Restricted stock units, remain unissued Offsetting Assets [Table] Offsetting Assets [Line Items] Line of credit Line of credit, interest rate Number of warrants to purchase Exercise price Warrants expiration date Warrants issued Warrants outstanding Warrants vested Warrants exercised Issuance of common stock Common stock remaining available of issuance Fair value of common stock Expected volatility Risk-free interest rate Term Fair value of warrants Unamortized debt issuance costs Litigation settlement payable Accrued interest Lease term Lease commencement date Lease payments Security deposit Assets, Current Assets [Default Label] Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Shares, Outstanding Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deferred Compensation Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Repayments of Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Forgone Recovery, Individual Name Outstanding Recovery, Individual Name Awards Close in Time to MNPI Disclosures, Individual Name Trading Arrangement, Individual Name RelatedPartyLoansPayableDisclosureTextBlock Cash and Cash Equivalents, Policy [Policy Text Block] DeferredOfferingCostsPoliciesTextBlock Lessee, Leases [Policy Text Block] Revenue [Policy Text Block] Research and Development Expense, Policy [Policy Text Block] Segment Reporting, Policy [Policy Text Block] AccruedCompensation Loans Payable, Current Repayments of Notes Payable ReclassificationOfDeferredOfferingCostsToApicAtCompletionOfOffering Commitments, Fair Value Disclosure Deferred Offering Costs Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Settlement Liabilities, Current